Publikationen in Zusammenarbeit mit Forschern von Hospital de Câncer de Barretos (2)

2023

  1. Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis

    American Journal of Hematology

2022

  1. MM-188 Depth of Response of Isatuximab plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: IKEMA Updated Analysis

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S411-S412